Works by Fujimoto, Daichi


Results: 64
    1
    2
    3
    4

    Real-world clinical outcomes of percutaneous transluminal septal myocardial ablation for patients with drug-refractory hypertrophic obstructive cardiomyopathy: results from a retrospective multicenter registry of non-high-volume centers.

    Published in:
    Heart & Vessels, 2022, v. 37, n. 11, p. 1937, doi. 10.1007/s00380-022-02100-4
    By:
    • Nakamura, Koichi;
    • Toba, Takayoshi;
    • Otake, Hiromasa;
    • Kakizaki, Shunsuke;
    • Fujimoto, Daichi;
    • Takahashi, Yu;
    • Fukuyama, Yusuke;
    • Kawamori, Hiroyuki;
    • Tanaka, Hidekazu;
    • Takaya, Tomofumi;
    • Iwasaki, Masamichi;
    • Kozuki, Amane;
    • Kawai, Hiroya;
    • Hayashi, Takatoshi;
    • Shite, Junya;
    • Hirata, Ken-ichi
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11

    Protruding Aortic Plaque and Coronary Plaque Vulnerability.

    Published in:
    Journal of the American Heart Association, 2024, v. 13, n. 2, p. 1, doi. 10.1161/JAHA.123.032742
    By:
    • Haruhito Yuki;
    • Isselbacher, Eric;
    • Takayuki Niida;
    • Keishi Suzuki;
    • Daisuke Kinoshita;
    • Daichi Fujimoto;
    • Hang Lee;
    • McNulty, Iris;
    • Sunao Nakamura;
    • Tsunekazu Kakuta;
    • Ik-Kyung Jang
    Publication type:
    Article
    12
    13
    14

    Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis.

    Published in:
    Clinical & Experimental Metastasis, 2014, v. 31, n. 5, p. 543, doi. 10.1007/s10585-014-9648-3
    By:
    • Fujimoto, Daichi;
    • Ueda, Hiroyuki;
    • Shimizu, Ryoko;
    • Kato, Ryoji;
    • Otoshi, Takehiro;
    • Kawamura, Takahisa;
    • Tamai, Koji;
    • Shibata, Yumi;
    • Matsumoto, Takeshi;
    • Nagata, Kazuma;
    • Otsuka, Kyoko;
    • Nakagawa, Atsushi;
    • Otsuka, Kojiro;
    • Katakami, Nobuyuki;
    • Tomii, Keisuke
    Publication type:
    Article
    15

    Clinical Significance of Bone Metastases in Pleural Mesothelioma.

    Published in:
    Thoracic Cancer, 2025, v. 16, n. 5, p. 1, doi. 10.1111/1759-7714.70033
    By:
    • Miyake, Mitsutomi;
    • Kuribayashi, Kozo;
    • Doi, Hiroshi;
    • Kubota, Aki;
    • Otuski, Taiichiro;
    • Negi, Yoshiki;
    • Mikami, Koji;
    • Takahashi, Ryo;
    • Nakamura, Akifumi;
    • Nakajima, Yasuhiro;
    • Fujimoto, Daichi;
    • Kitajima, Kazuhiro;
    • Minami, Toshiyuki;
    • Kijima, Takashi
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    A Phase II Study to Assess the Efficacy of Osimertinib in Patients With EGFR Mutation-positive NSCLC Who Developed Isolated CNS Progression (T790M-negative or Unknown) During First- or Second-generation EGFR-TKI or Systemic Disease Progression (T790M-negative) After Treatment With First- or Second-generation EGFR-TKI and Platinum-based Chemotherapy (WJOG12819L)

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 4, p. 376, doi. 10.1016/j.cllc.2020.12.009
    By:
    • Takeda, Masayuki;
    • Shimokawa, Mototsugu;
    • Nakamura, Atsushi;
    • Nosaki, Kaname;
    • Watanabe, Yasutaka;
    • Kato, Terufumi;
    • Hayakawa, Daisuke;
    • Tanaka, Hiroshi;
    • Takahashi, Toshiaki;
    • Kogure, Yoshihito;
    • Tachihara, Motoko;
    • Fujimoto, Daichi;
    • Yamaguchi, Kakuhiro;
    • Hamaguchi, Naohiko;
    • Okamoto, Isamu;
    • Azuma, Koichi;
    • Hasegawa, Kazuo;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    26

    Association Between Early Immune-related Adverse Events and Clinical Outcomes in Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.

    Published in:
    2020
    By:
    • Hosoya, Kazutaka;
    • Fujimoto, Daichi;
    • Morimoto, Takeshi;
    • Kumagai, Toru;
    • Tamiya, Akihiro;
    • Taniguchi, Yoshihiko;
    • Yokoyama, Toshihide;
    • Ishida, Tadashi;
    • Hirano, Katsuya;
    • Matsumoto, Hirotaka;
    • Kominami, Ryota;
    • Tomii, Keisuke;
    • Suzuki, Hidekazu;
    • Hirashima, Tomonori;
    • Uchida, Junji;
    • Morita, Mitsunori;
    • Kanazu, Masaki;
    • Sawa, Nobuhiko;
    • Makio, Takeshi;
    • Hara, Satoshi
    Publication type:
    journal article
    27
    28
    29
    30

    Evaluation of the usefulness of protocol‐based pharmacist‐facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer.

    Published in:
    Journal of Clinical Pharmacy & Therapeutics, 2020, v. 45, n. 6, p. 1288, doi. 10.1111/jcpt.13207
    By:
    • Ikesue, Hiroaki;
    • Kusuda, Kaori;
    • Satsuma, Yukari;
    • Nishiwaki, Fuki;
    • Miura, Rieko;
    • Masuda, Yoshio;
    • Hirabatake, Masaki;
    • Muroi, Nobuyuki;
    • Fujimoto, Daichi;
    • Morimoto, Takeshi;
    • Tomii, Keisuke;
    • Hashida, Tohru
    Publication type:
    Article
    31
    32

    Clinical outcomes in non-small cell lung cancer patients with an ultra-high expression of programmed death ligand-1 treated using pembrolizumab as a first-line therapy: A retrospective multicenter cohort study in Japan.

    Published in:
    PLoS ONE, 2019, v. 14, n. 7, p. 1, doi. 10.1371/journal.pone.0220570
    By:
    • Ryuya Edahiro;
    • Masaki Kanazu;
    • Hiroyuki Kurebe;
    • Masahide Mori;
    • Daichi Fujimoto;
    • Yoshihiko Taniguchi;
    • Hidekazu Suzuki;
    • Katsuya Hirano;
    • Toshihide Yokoyama;
    • Mitsunori Morita;
    • Yasushi Fukuda;
    • Junji Uchida;
    • Takeshi Makio;
    • Motohiro Tamiya
    Publication type:
    Article
    33
    34
    35

    The safety and efficacy of paclitaxel and carboplatin with or without bevacizumab for treating patients with advanced nonsquamous non-small cell lung cancer with interstitial lung disease.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 6, p. 1159, doi. 10.1007/s00280-014-2590-x
    By:
    • Shimizu, Ryoko;
    • Fujimoto, Daichi;
    • Kato, Ryoji;
    • Otoshi, Takehiro;
    • Kawamura, Takahisa;
    • Tamai, Koji;
    • Matsumoto, Takeshi;
    • Nagata, Kazuma;
    • Otsuka, Kyoko;
    • Nakagawa, Atsushi;
    • Otsuka, Kojiro;
    • Katakami, Nobuyuki;
    • Tomii, Keisuke
    Publication type:
    Article
    36

    Reply to a letter.

    Published in:
    2025
    By:
    • Fujimoto, Daichi;
    • Obata, Norihiko;
    • Mizobuchi, Satoshi
    Publication type:
    Letter
    37
    38
    39
    40
    41
    42

    Outcomes of Chemoimmunotherapy Among Patients With Extensive-Stage Small Cell Lung Cancer According to Potential Clinical Trial Eligibility.

    Published in:
    JAMA Network Open, 2023, v. 6, n. 2, p. e230698, doi. 10.1001/jamanetworkopen.2023.0698
    By:
    • Fujimoto, Daichi;
    • Morimoto, Takeshi;
    • Tamiya, Motohiro;
    • Hata, Akito;
    • Matsumoto, Hirotaka;
    • Nakamura, Atsushi;
    • Yokoyama, Toshihide;
    • Taniguchi, Yoshihiko;
    • Uchida, Junji;
    • Sato, Yuki;
    • Yokoi, Takashi;
    • Tanaka, Hisashi;
    • Furuya, Naoki;
    • Masuda, Takeshi;
    • Sakata, Yoshihiko;
    • Miyauchi, Eisaku;
    • Hara, Satoshi;
    • Saito, Go;
    • Miura, Satoru;
    • Kanazu, Masaki
    Publication type:
    Article
    43

    Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin‐based chemotherapy using short hydration: A randomized phase II trial.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 4, p. 1, doi. 10.1002/cam4.6839
    By:
    • Murakami, Eriko;
    • Akamatsu, Hiroaki;
    • Teraoka, Shunsuke;
    • Takakura, Toshiaki;
    • Takase, Eri;
    • Tanaka, Masanori;
    • Kaki, Takahiro;
    • Harutani, Yuhei;
    • Furuta, Katsuyuki;
    • Sugimoto, Takeya;
    • Shibaki, Ryota;
    • Fujimoto, Daichi;
    • Hayata, Atsushi;
    • Ozawa, Yuichi;
    • Nakanishi, Masanori;
    • Koh, Yasuhiro;
    • Shimokawa, Toshio;
    • Yamamoto, Nobuyuki
    Publication type:
    Article
    44
    45

    Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-30676-y
    By:
    • Fujimoto, Daichi;
    • Miura, Satoru;
    • Tomii, Keisuke;
    • Sumikawa, Hiromitsu;
    • Yoshimura, Kenichi;
    • Wakuda, Kazushige;
    • Oya, Yuko;
    • Yokoyama, Toshihide;
    • Kijima, Takashi;
    • Asao, Tetsuhiko;
    • Tamiya, Motohiro;
    • Nakamura, Atsushi;
    • Yoshioka, Hiroshige;
    • Tokito, Takaaki;
    • Murakami, Shuji;
    • Tamiya, Akihiro;
    • Yokouchi, Hiroshi;
    • Watanabe, Satoshi;
    • Yamaguchi, Ou;
    • Morinaga, Ryotaro
    Publication type:
    Article
    46
    47
    48
    49
    50

    Classification and regression tree for estimating predictive markers to detect T790M mutations after acquired resistance to first line EGFR-TKI: HOPE-002.

    Published in:
    Investigational New Drugs, 2022, v. 40, n. 2, p. 361, doi. 10.1007/s10637-021-01203-5
    By:
    • Tamiya, Motohiro;
    • Fujikawa, Kei;
    • Suzuki, Hidekazu;
    • Yokoyama, Toshihide;
    • Uenami, Takeshi;
    • Tamiya, Akihiro;
    • Sato, Yuki;
    • Saito, Go;
    • Uchida, Junji;
    • Morita, Mitsunori;
    • Hirashima, Tomonori;
    • Fukuda, Yasushi;
    • Kanazu, Masaki;
    • Hosoya, Kazutaka;
    • Suzuki, Takuji;
    • Ueno, Kiyonobu;
    • Fujimoto, Daichi;
    • Kumagai, Toru;
    • Teramukai, Satoshi
    Publication type:
    Article